Kohei Yamazaki

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Cell Proliferation

Tyrosine Kinase

Multiple Myeloma

Endoplasmic Reticulum Stress

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mikio Okayama, Kota Fujimori, Mariko Sato, Koichi Samata, Koki Kurita, Hiromu Sugiyama, Yutaka Suto, Genji Iwasaki, Taketo Yamada, Fumiyuki Kiuchi, Daiju Ichikawa, Maiko Matsushita, Maki Hirao, Hisako Kunieda, Kohei Yamazaki, Yutaka Hattori
GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c-MET tyrosine kinase. Cancer medicine (2023)
Maki Hirao, Kohei Yamazaki, Kentaro Watanabe, Kiyoshi Mukai, Shigemichi Hirose, Makoto Osada, Yuiko Tsukada, Hisako Kunieda, Ryunosuke Denda, Takahide Kikuchi, Hiroki Sugimori, Shinichiro Okamoto, Yutaka Hattori
Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease. F1000Research 11 (2022)